Open access · OA
via OpenAlex
Evaluating Alzheimer's disease biomarkers as mediators of age-related cognitive decline
Timothy J. Hohman, Douglas Tommet, Shawn M. Marks, Joey Annette Contreras, Richard Norman Jones, Dan Mungas
Neurobiology of Aging · 2017 · ▲ 31 citations
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1016/j.neurobiolaging.2017.06.022
- Canonical
- link ↗
- Fetched
- 2026-10-17 MST
Cite this
APA
Hohman, T.J., Tommet, D., Marks, S.M., Contreras, J.A., Jones, R.N., & Mungas, D. (2017). Evaluating Alzheimer's disease biomarkers as mediators of age-related cognitive decline. <em>Neurobiology of Aging</em>. https://doi.org/10.1016/j.neurobiolaging.2017.06.022
Vancouver
Hohman TJ, Tommet D, Marks SM, Contreras JA, Jones RN, Mungas D. Evaluating Alzheimer's disease biomarkers as mediators of age-related cognitive decline. Neurobiology of Aging. 2017. doi:10.1016/j.neurobiolaging.2017.06.022.
BibTeX
@article{timothy2017Evalua,
title = {Evaluating Alzheimer's disease biomarkers as mediators of age-related cognitive decline},
author = {Timothy J. Hohman and Douglas Tommet and Shawn M. Marks and Joey Annette Contreras and Richard Norman Jones and Dan Mungas},
journal = {Neurobiology of Aging},
year = {2017},
doi = {10.1016/j.neurobiolaging.2017.06.022},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Nature Reviews Neurology 2010
Citation only
Cognitive intervention in Alzheimer disease
The Lancet 2021
Preprint · OA
Alzheimer's disease
Handbook of clinical neurology 2019
Citation only
Alzheimer's disease
Nature Reviews Neurology 2024
Preprint · OA
Is Alzheimer disease a disease?
Neurochemical Research 1995
Citation only
Neural membrane phospholipids in alzheimer disease
Life 2021
Open access · CC-BY